聚焦亚太市场,德国儿童营养品牌inne亮相Vitafoods Asia,引领科学育儿趋势
Jiang Nan Shi Bao·2025-10-09 02:34

Core Insights - The Vitafoods Asia 2025 event successfully gathered over 650 exhibitors and 13,000 professional visitors from 38 countries, focusing on "natural nutrition, functional innovation, and sustainable development" [1] Group 1: Market Trends - The children's nutrition market in the Asia-Pacific region is rapidly growing due to the evolving family structures and consumption upgrades, with parents demanding higher safety and effectiveness in nutritional supplements [2] - Inne's product range addresses key areas such as bone development, vision protection, brain development, and immune support, aligning with the nutritional needs of families in the region [2] Group 2: Product Highlights - Inne's calcium series products, particularly the liquid calcium for children under 6 and the bamboo calcium for adolescents, have garnered attention for their innovative formulations and clinical research backing [2] - The eye care products, including the Blue Light Shield gummies and Vision Stick, are designed for different age groups and have shown positive effects on children's retinal health and axial growth [2] Group 3: Market Reception - The product experience area at the event received positive feedback, with attendees expressing interest in Inne's liquid calcium due to its convenience and high absorption rate [3] - Several distributors from Southeast Asia showed keen interest in Inne's products, highlighting the unique appeal of the jelly-like probiotic and the effective liquid calcium formulation [3][4] Group 4: Research and Development - Inne has established a global R&D system with five centers in Germany, China, the USA, and Italy, and has formed the Inne Nutrition and Health Research Institute to focus on cutting-edge research in children's nutrition [5] - The company aims to optimize product formulations based on the growth characteristics and dietary habits of children in the Asia-Pacific region, collaborating with local institutions for clinical research [6]